These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15939331)

  • 21. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural unit analysis identifies lead series and facilitates scaffold hopping in combinatorial chemistry.
    Wolohan PR; Akella LB; Dorfman RJ; Nell PG; Mundt SM; Clark RD
    J Chem Inf Model; 2006; 46(3):1188-93. PubMed ID: 16711738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concept of Focused Diversity: a new algorithm for building screening libraries.
    Kiselyov AS
    IDrugs; 2006 Mar; 9(3):193-8. PubMed ID: 16523385
    [No Abstract]   [Full Text] [Related]  

  • 25. Natural products from cyanobacteria: Exploiting a new source for drug discovery.
    Sielaff H; Christiansen G; Schwecke T
    IDrugs; 2006 Feb; 9(2):119-27. PubMed ID: 16523402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicomponent reactions in solid-phase synthesis.
    Banfi L; Guanti G; Riva R; Basso A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
    Massarelli I; Macchia M; Minutolo F; Prota G; Bianucci AM
    Bioorg Med Chem; 2009 May; 17(10):3543-56. PubMed ID: 19398207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo-differentiating ABB' multicomponent reactions. Privileged building blocks.
    Tejedor D; García-Tellado F
    Chem Soc Rev; 2007 Mar; 36(3):484-91. PubMed ID: 17325787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging chemical and biological approaches for the preparation of discovery libraries.
    Boldt GE; Dickerson TJ; Janda KD
    Drug Discov Today; 2006 Feb; 11(3-4):143-8. PubMed ID: 16533712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A scalable approach to combinatorial library design for drug discovery.
    Sharma P; Salapaka S; Beck C
    J Chem Inf Model; 2008 Jan; 48(1):27-41. PubMed ID: 18052333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay between structure-based design and combinatorial chemistry.
    Rupasinghe CN; Spaller MR
    Curr Opin Chem Biol; 2006 Jun; 10(3):188-93. PubMed ID: 16616591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concise and diversity-oriented synthesis of novel scaffolds embedded with privileged benzopyran motif.
    Ko SK; Jang HJ; Kim E; Park SB
    Chem Commun (Camb); 2006 Jul; (28):2962-4. PubMed ID: 16832504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors.
    Webb TR; Jiang L; Sviridov S; Venegas RE; Vlaskina AV; McGrath D; Tucker J; Wang J; Deschenes A; Li R
    J Comb Chem; 2007; 9(4):704-10. PubMed ID: 17429950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinatorial chemistry in the agrosciences.
    Lindell SD; Pattenden LC; Shannon J
    Bioorg Med Chem; 2009 Jun; 17(12):4035-46. PubMed ID: 19349185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical appraisal of structure-based drug design.
    Tintelnot-Blomley M; Lewis RA
    IDrugs; 2006 Feb; 9(2):114-8. PubMed ID: 16523401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.